RGAVX
Price
$14.98
Change
-$0.10 (-0.66%)
Updated
Nov 19 closing price
Net Assets
149.72M
VCRQX
Price
$14.61
Change
-$0.10 (-0.68%)
Updated
Nov 19 closing price
Net Assets
1.38B
Interact to see
Advertisement

RGAVX vs VCRQX

Header iconRGAVX vs VCRQX Comparison
Open Charts RGAVX vs VCRQXBanner chart's image
ClearBridge Global Infrastructure Inc A
Price$14.98
Change-$0.10 (-0.66%)
VolumeN/A
Net Assets149.72M
NYLI CBRE Global Infrastructure Class R6
Price$14.61
Change-$0.10 (-0.68%)
VolumeN/A
Net Assets1.38B
RGAVX vs VCRQX Comparison Chart in %
View a ticker or compare two or three
VS
RGAVX vs. VCRQX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAVX is a Hold and VCRQX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCRQX has more cash in the bank: 1.38B vs. RGAVX (150M). RGAVX pays higher dividends than VCRQX: RGAVX (2.53) vs VCRQX (2.09). RGAVX was incepted earlier than VCRQX: RGAVX (10 years) vs VCRQX (6 years). RGAVX (1.42) is less costly to investors than VCRQX (0.90). VCRQX is a more actively managed with annual turnover of: 81.00 vs. RGAVX (73.00). VCRQX has a lower initial minimum investment than RGAVX: VCRQX (0) vs RGAVX (1000). RGAVX annual gain was more profitable for investors over the last year : 18.99 vs. VCRQX (8.77). VCRQX (39.07) and RGAVX (37.66) have equivalent 5 years return.
RGAVXVCRQXRGAVX / VCRQX
Total Expense Ratio1.300.90144%
Annual Report Gross Expense Ratio1.420.90158%
Fund Existence10 years6 years-
Gain YTD24.95113.727182%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets150M1.38B11%
Annual Yield % from dividends2.532.09121%
Returns for 1 year18.998.77216%
Returns for 3 years27.0026.81101%
Returns for 5 years37.6639.0796%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUERX36.580.13
+0.36%
MFS Blended Research Core Equity R1
DHLTX25.19N/A
N/A
Diamond Hill Select I
RDCCX8.71N/A
N/A
Columbia Disciplined Value C
SHPAX22.06N/A
N/A
Saratoga Health & Biotechnology A
JBATX31.83N/A
N/A
JHancock Balanced R2